Recombinant multi-species CYFIP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CYFIP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that regulates cytoskeletal dynamics and protein translation. The encoded protein is a component of the WAVE regulatory complex (WRC), which promotes actin polymerization. This protein also interacts with the synaptic functional regulator FMR1 protein and translation initiation factor 4E to inhibit protein translation. A large chromosomal deletion including this gene is associated with increased risk of schizophrenia and epilepsy in human patients. Reduced expression of this gene has been observed in various human cancers and the encoded protein may inhibit tumor invasion. [provided by RefSeq, Mar 2022]
The Alternative Names of target: CYFIP1,Cyfip1,Cytoplasmic FMR1-interacting protein 1,E030028J09Rik,P140SRA-1,P140sra1,SHYC,SRA-1,SRA1,Shyc,Specifically Rac1-associated protein 1 (Sra-1),Sra-1,Sra1,l(7)1Rl,l71Rl,l7Rl1,mKIAA0068,p140sra-1,pl-1

Target products collectionGo to CYFIP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6763-Ag-1/ GM-Tg-hg-IP6763-Ag-2 Human CYFIP1 protein Human
GM-Tg-rg-IP6763-Ag-1/ GM-Tg-rg-IP6763-Ag-2 Rat CYFIP1 protein Rat
GM-Tg-mg-IP6763-Ag-1/ GM-Tg-mg-IP6763-Ag-2 Mouse CYFIP1 protein Mouse
GM-Tg-cynog-IP6763-Ag-1/ GM-Tg-cynog-IP6763-Ag-2 Cynomolgus/Rhesus macaque CYFIP1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6763-Ag-1/ GM-Tg-felg-IP6763-Ag-2 Feline CYFIP1 protein Feline
GM-Tg-cang-IP6763-Ag-1/ GM-Tg-cang-IP6763-Ag-2 Canine CYFIP1 protein Canine
GM-Tg-bovg-IP6763-Ag-1/ GM-Tg-bovg-IP6763-Ag-2 Bovine CYFIP1 protein Bovine
GM-Tg-equg-IP6763-Ag-1/ GM-Tg-equg-IP6763-Ag-2 Equine CYFIP1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6763-Ag-1/ GM-Tg-hg-IP6763-Ag-2; GM-Tg-rg-IP6763-Ag-1/ GM-Tg-rg-IP6763-Ag-2;
GM-Tg-mg-IP6763-Ag-1/ GM-Tg-mg-IP6763-Ag-2; GM-Tg-cynog-IP6763-Ag-1/ GM-Tg-cynog-IP6763-Ag-2;
GM-Tg-felg-IP6763-Ag-1/ GM-Tg-felg-IP6763-Ag-2; GM-Tg-cang-IP6763-Ag-1/ GM-Tg-cang-IP6763-Ag-2;
GM-Tg-bovg-IP6763-Ag-1/ GM-Tg-bovg-IP6763-Ag-2; GM-Tg-equg-IP6763-Ag-1/ GM-Tg-equg-IP6763-Ag-2
Products Name CYFIP1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CYFIP1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CYFIP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.